Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2016-001816-39-BE
EUCTR2016-001816-39-BE
Active, not recruiting
Phase 1

Phase III randomized trial comparating concomittant administration of radiotherapy with cisplatin versus radiotherapy only for treatment of sinuses tumors and salivary glands

GORTEC0 sites342 target enrollmentApril 28, 2020
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsCisplatine hospira

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
GORTEC
Enrollment
342
Status
Active, not recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 28, 2020
End Date
TBD
Last Updated
last year
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
GORTEC

Eligibility Criteria

Inclusion Criteria

  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) yes
  • •F.1\.2\.1 Number of subjects for this age range 292
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range 50

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Phase 1
A phase III randomised study comparing concomitant radiochemotherapy with cisplatin and docetaxel as induction versus consolidation treatment in patients with locally advanced unresectable non-small cell lung cancernresectable non metastatic stage III non small cell lung carcinoma eligible for concomitant radiochemotherapyMedDRA version: 9.1Level: HLGTClassification code 10038666Term: Respiratory and mediastinal neoplasms malignant and unspecified
EUCTR2006-004726-91-FRCHRU de Lille246
Completed
Not Applicable
Phase III randomized comparative study of combination therapy with CDDP and TS-1 vs. combination therapy with CDDP and Docetaxel in stage IIIB/IV non-small cell lung cancerStage IIIB/IV or ppstoperative recurrent non-small sell lung cancer
JPRN-UMIN000000608The Tokyo cooperative oncology group600
Completed
Phase 3
Study to find out if restricting raw fruits in patients with blood cancer can reduce infections.Health Condition 1: C910- Acute lymphoblastic leukemia [ALL]Health Condition 2: C920- Acute myeloblastic leukemiaHealth Condition 3: null- Patients with acute lymphoblastic leukemia or acute myeloid leukemia
CTRI/2018/01/011418Cancer Institute200
Completed
Phase 3
Steroid tablets for preventing tiredness in cancer patients receiving chemotherapy medicine.Health Condition 1: C509- Malignant neoplasm of breast of unspecified siteHealth Condition 2: C348- Malignant neoplasm of overlappingsites of bronchus and lung
CTRI/2018/08/015222Cancer Institute126
Recruiting
Phase 1
A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of two formulations of vaginal micronized progesterone.infertilityTherapeutic area: Diseases [C] - Female Urogenital Diseases and Pregnancy Complications [C13]
CTIS2024-513102-57-00Santiago Dexeus Font Fundacio Privada1,020